Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_assertion type Assertion NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_head.
- NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_assertion description "[Both T2DM and OB group had significantly increased serum concentrations of circulating proinflammatory factors (C-reactive protein, TNF?, IL-6, IL-8), mRNA expression of macrophage antigen CD68 and proinflammatory chemokines (CCL-2, -3, -7, -8, -17, -22) in SCAT and complementary chemokine receptors (CCR-1, -2, -3, -5) and other proinflammatory receptors (toll-like receptor 2 and 4, TNF receptor superfamily 1A and 1B, IL-6R) in PM, with OB group showing less pronounced chemoattracting and proinflammatory profile compared to T2DM group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_provenance.
- NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_assertion evidence source_evidence_literature NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_provenance.
- NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_assertion SIO_000772 21289263 NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_provenance.
- NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_assertion wasDerivedFrom befree-20140225 NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_provenance.
- NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_assertion wasGeneratedBy ECO_0000203 NP256196.RAlIP8-_r-ow0OCviRN1f7Q_sihyoxoNlBgbcp9UpGF_0130_provenance.